Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
ClinicalTrials.gov study NCT07159607. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
ClinicalTrials.gov study NCT01149434. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
ClinicalTrials.gov study NCT06024174. IPD Sharing: YES. Countries: 5. Publications: 0.
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
ClinicalTrials.gov study NCT04410796. IPD Sharing: YES. Countries: 1. Publications: 0.
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05493501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy
ClinicalTrials.gov study NCT02186301. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors
ClinicalTrials.gov study NCT05003622. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis
ClinicalTrials.gov study NCT03911869. IPD Sharing: YES. Countries: 5. Publications: 0.
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
ClinicalTrials.gov study NCT05246514. IPD Sharing: YES. Countries: 1. Publications: 0.
Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02147990. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05377788. IPD Sharing: NO. Countries: 1. Publications: 1.
CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC
ClinicalTrials.gov study NCT06557096. IPD Sharing: NO. Countries: 0. Publications: 5.
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04971187. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.
ClinicalTrials.gov study NCT03755102. IPD Sharing: YES. Countries: 1. Publications: 0.
Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04120454. IPD Sharing: NO. Countries: 1. Publications: 0.
Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT02191891. IPD Sharing: YES. Countries: 4. Publications: 0.
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With t
ClinicalTrials.gov study NCT01726738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trametinib in Patients With Advanced Neurofibromatosis Type 1 (NF1)-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03232892. IPD Sharing: NO. Countries: 1. Publications: 0.
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
ClinicalTrials.gov study NCT03922555. IPD Sharing: YES. Countries: 1. Publications: 0.
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
ClinicalTrials.gov study NCT03718767. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.